Peter Kasper

2.7k total citations
42 papers, 1.1k citations indexed

About

Peter Kasper is a scholar working on Cancer Research, Molecular Biology and Small Animals. According to data from OpenAlex, Peter Kasper has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cancer Research, 14 papers in Molecular Biology and 12 papers in Small Animals. Recurrent topics in Peter Kasper's work include Carcinogens and Genotoxicity Assessment (30 papers), Animal testing and alternatives (12 papers) and Effects and risks of endocrine disrupting chemicals (11 papers). Peter Kasper is often cited by papers focused on Carcinogens and Genotoxicity Assessment (30 papers), Animal testing and alternatives (12 papers) and Effects and risks of endocrine disrupting chemicals (11 papers). Peter Kasper collaborates with scholars based in Germany, Switzerland and United States. Peter Kasper's co-authors include Lutz Müller, Raffaella Corvi, David Kirkland, Günter Speit, Federica Madia, Jan van Benthem, Hans-Jörg Martus, Stephan Madle, Makoto Hayashi and Véronique Thybaud and has published in prestigious journals such as Mutation research. Fundamental and molecular mechanisms of mutagenesis, Advances in experimental medicine and biology and Toxicology Letters.

In The Last Decade

Peter Kasper

41 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Kasper Germany 19 714 428 390 299 189 42 1.1k
David Tweats United Kingdom 20 492 0.7× 375 0.9× 228 0.6× 203 0.7× 114 0.6× 45 1.2k
Hiroyasu Shimada Japan 21 720 1.0× 670 1.6× 401 1.0× 341 1.1× 106 0.6× 46 1.6k
Anthony M. Lynch United Kingdom 24 933 1.3× 817 1.9× 363 0.9× 235 0.8× 143 0.8× 51 1.7k
Alan L. Mendrala United States 13 510 0.7× 313 0.7× 367 0.9× 168 0.6× 69 0.4× 17 998
Patricia A. Escobar United States 13 473 0.7× 232 0.5× 266 0.7× 218 0.7× 65 0.3× 21 826
Angela E. Auletta United States 15 735 1.0× 361 0.8× 322 0.8× 378 1.3× 89 0.5× 29 1.1k
Atsushi Hakura Japan 20 552 0.8× 499 1.2× 185 0.5× 211 0.7× 41 0.2× 63 1.1k
Motoi Ishidate Japan 11 886 1.2× 566 1.3× 425 1.1× 396 1.3× 67 0.4× 28 1.5k
Verne A. Ray United States 15 577 0.8× 393 0.9× 233 0.6× 237 0.8× 42 0.2× 27 935
F. Romagna Japan 10 566 0.8× 313 0.7× 388 1.0× 213 0.7× 37 0.2× 15 1.0k

Countries citing papers authored by Peter Kasper

Since Specialization
Citations

This map shows the geographic impact of Peter Kasper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kasper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kasper more than expected).

Fields of papers citing papers by Peter Kasper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kasper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kasper. The network helps show where Peter Kasper may publish in the future.

Co-authorship network of co-authors of Peter Kasper

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Kasper. A scholar is included among the top collaborators of Peter Kasper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Kasper. Peter Kasper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beken, Sonja, et al.. (2016). Regulatory Acceptance of Alternative Methods in the Development and Approval of Pharmaceuticals. Advances in experimental medicine and biology. 856. 33–64. 23 indexed citations
2.
Kirkland, David, Peter Kasper, Hans-Jörg Martus, et al.. (2015). Updated recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 795. 7–30. 139 indexed citations
3.
Martus, Hans‐Joerg, Makoto Hayashi, Masamitsu Honma, et al.. (2015). Summary of major conclusions from the 6th International Workshop on Genotoxicity Testing (IWGT), Foz do Iguaçu, Brazil. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 783. 1–5. 6 indexed citations
4.
Speit, Günter, Hajime Kojima, Brian Burlinson, et al.. (2014). Critical issues with the in vivo comet assay: A report of the comet assay working group in the 6th International Workshop on Genotoxicity Testing (IWGT). Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 783. 6–12. 49 indexed citations
5.
Kirkland, David, Errol Zeiger, Federica Madia, et al.. (2014). Can in vitro mammalian cell genotoxicity test results be used to complement positive results in the Ames test and help predict carcinogenic or in vivo genotoxic activity? I. Reports of individual databases presented at an EURL ECVAM Workshop. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 775-776. 55–68. 50 indexed citations
6.
Hayashi, Makoto, Kerry L. Dearfield, Peter Kasper, et al.. (2010). Compilation and use of genetic toxicity historical control data. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 723(2). 87–90. 40 indexed citations
7.
Pfuhler, Stefan, David Kirkland, Peter Kasper, et al.. (2009). Reduction of use of animals in regulatory genotoxicity testing: Identification and implementation opportunities—Report from an ECVAM workshop. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 680(1-2). 31–42. 76 indexed citations
8.
Thybaud, Véronique, Marilyn J. Aardema, Daniel A. Casciano, et al.. (2007). Relevance and follow-up of positive results in in vitro genetic toxicity assays: An ILSI-HESI initiative. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 633(2). 67–79. 27 indexed citations
9.
Kasper, Peter, Yoshifumi Uno, Robert J. Mauthe, et al.. (2006). Follow-up testing of rodent carcinogens not positive in the standard genotoxicity testing battery: IWGT workgroup report. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 627(1). 106–116. 13 indexed citations
10.
Frötschl, Roland, et al.. (2005). Effects of chlorpromazine with and without UV irradiation on gene expression of HepG2 cells. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 575(1-2). 47–60. 8 indexed citations
11.
Hartwig, A., Peter Kasper, Stephan Madle, et al.. (2001). The potential use of mutation spectra in cancer related genes in genetic toxicology: a statement of a GUM working group. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 473(2). 263–267. 2 indexed citations
12.
Hude, Wilhelm von der, S. Kalweit, Günter Engelhardt, et al.. (2000). In vitro micronucleus assay with Chinese hamster V79 cells — results of a collaborative study with in situ exposure to 26 chemical substances. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 468(2). 137–163. 74 indexed citations
13.
Müller, Lutz, Peter Kasper, Birgit Kersten, & Juan Zhang. (1998). Photochemical genotoxicity and photochemical carcinogenesis — Two sides of a Coin?. Toxicology Letters. 102-103. 383–387. 18 indexed citations
14.
Müller, Kerstin, Peter Kasper, & Lutz Müller. (1993). An assessment of the in vitro hepatocyte micronucleus assay. Mutation Research/Environmental Mutagenesis and Related Subjects. 292(3). 213–224. 31 indexed citations
15.
Müller, Lutz, et al.. (1992). The clastogenic potential in vitro of pyrrolizidine alkaloids employing hepatocyte metabolism. Mutation Research Letters. 282(3). 169–176. 24 indexed citations
16.
Müller, Lutz, Peter Kasper, & Stephan Madle. (1991). Further investigations on the clastogenicity of paracetamol and acetylsalicylic acid in vitro. Mutation Research Letters. 263(2). 83–92. 15 indexed citations
17.
Müller, Lutz, Peter Kasper, & Stephan Madle. (1991). The quality of genotoxicity testing of drugs. Experiences of a regulatory agency with new and old compounds. Mutagenesis. 6(2). 143–149. 12 indexed citations
18.
Kasper, Peter, Stephan Madle, & Elisabeth George. (1988). Induction of SCE by indirect mutagens in cultured rat hepatoma cells and in Chinese hamster V79 cells co-cultivated with hepatocyte primary cultures. Mutagenesis. 3(6). 521–525. 5 indexed citations
19.
Kasper, Peter, et al.. (1987). Hepatocyte activation of indirect mutagens during the first days in primary culture. Mutagenesis. 2(5). 337–340. 1 indexed citations
20.
Stadler, Hermann, et al.. (1980). Verstehen und Gestalten. R. Oldenbourg eBooks. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026